Design (Testphase)
Momentum & Trend
Power Trend
1,147
Hits
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Market filter active: the list shows 100 hits from US
Minervini/Qullamaggie Power Trend: the daily low has stayed above the 21-day EMA for at least 10 days, the 21-EMA has been above the 50-day SMA for at least 5 days, and the 50-SMA is rising — the condition in which trend traders are fully invested. When the Power Trend ends, they reduce risk.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(17)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EMA (Exponential Moving Average)
- Like the simple moving average, but more recent prices carry more weight - the line follows price faster. The 21-day EMA is the standard short-term trend line for momentum traders.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- SMA / Moving Average (10-, 20-, 50-, 200-Day Line)
- The average price of the last X days, plotted as a line on the chart (Simple Moving Average). The 50-day and 200-day lines are the most closely watched: price above the line = uptrend intact. The 30-week line from the Weinstein method corresponds to the 150-day line.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANRO Alto Neuroscience, Inc. | 08/12 | — | 89 8/22 | Stage 2 | D 26 | 2 of 9 | 1.0 $ | Biotechnology | – | — | — | Healthcare | 27.10 $ | +37.3 % | +41.2 % | +781.8 % | −11.0 % | +31.5 % | 99 | 42 | 8.0 % | 7.7 % | 1.07 | — | 0.0 | — | 3.9 | — | — | 0.0 | — | — | 0.0 % | -38.9 % | -21.7 % | 0.02 | — | -100.0 % | — | 0.0 % | 0.0 % | 12.7 | 82.1 % | 9.4 % | 4.6 (8) |
| CLYM Climb Bio Inc | 08/11 | +142 % | 93 9/22 | Stage 2 | D 33 | 3 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 11.90 $ | +207.5 % | +175.5 % | +750.0 % | −5.9 % | +75.2 % | 99 | 42 | 7.3 % | 8.2 % | 0.08 | — | 0.0 | — | 4.6 | — | — | 0.6 | — | — | 0.0 % | -30.9 % | -21.3 % | 0.00 | — | — | — | 0.0 % | 0.0 % | 35.4 | 66.5 % | 16.9 % | 5.0 (2) |
| WULF Terawulf Inc | 08/14 | +500 % | 53 5/22 | Stage 2 | D 38 | 2 of 9 | 8.9 $ | Capital Markets | – | — | — | Financial Services | 17.70 $ | +150.5 % | +107.8 % | +242.3 % | −12.7 % | +116.9 % | 98 | 42 | 8.4 % | 8.3 % | 4.26 | — | 29.8 | 52.9 | 57.2 | — | — | 75.5 | -366.2 % | 64.0 % | 0.0 % | -2,216.0 % | -3.4 % | -67.46 | -1.1 % | +20.3 % | — | 0.0 % | 0.0 % | 2.8 | 82.5 % | 24.8 % | 4.6 (11) |
| PRAX Praxis Precision Medicines Inc | 08/03 | +177 % | 96 10/22 | Stage 2 | C 54 | 4 of 9 | 8.5 $ | Biotechnology | – | — | — | Healthcare | 307.80 $ | +3.6 % | +27.6 % | +467.7 % | −10.6 % | +98.2 % | 98 | 42 | 6.8 % | 7.0 % | 2.76 | — | 0.0 | — | 5.7 | — | — | -6.9 | 0.0 % | -3,809.4 % | 0.0 % | -35.3 % | -23.0 % | 0.00 | 96.6 % | -100.0 % | — | 0.0 % | 0.0 % | 31.8 | 116.8 % | 13.5 % | 4.4 (12) |
| KOD Kodiak Sciences Inc | 08/12 | +137 % | 40 4/22 | Stage 2 | E 23 | 2 of 9 | 2.6 $ | Biotechnology | – | — | — | Healthcare | 41.60 $ | +32.5 % | +21.4 % | +532.4 % | −28.7 % | +51.4 % | 98 | 42 | 8.0 % | 7.7 % | 2.20 | — | 0.0 | — | — | — | — | -0.1 | 0.0 % | — | 0.0 % | -208.8 % | -49.1 % | — | 36.6 % | — | — | 0.0 % | 0.0 % | -15.7 | 99.6 % | 26.4 % | 2.8 (6) |
| BAND Bandwidth Inc | 07/29 | +106 % | 87 9/25 | Stage 2 | C 50 | 7 of 9 | 1.3 $ | Software - Infrastructure | Sells AI | — | Technology | 39.10 $ | +241.3 % | +304.3 % | +181.4 % | −31.1 % | +72.0 % | 98 | 42 | 8.6 % | 8.7 % | 2.92 | — | 23.0 | 1.6 | 3.1 | 16.3 | — | 27.4 | -2.2 % | 37.2 % | 0.3 % | -1.4 % | -0.9 % | 1.04 | 41.2 % | +0.7 % | — | 0.0 % | 0.0 % | 3.6 | 80.1 % | 12.2 % | 3.3 (6) | |
| SLS Sellas Life Sciences Group Inc | 08/11 | +148 % | — | Stage 2 | C 53 | 3 of 9 | 0.0 $ | Biotechnology | Uses AI | — | Healthcare | 10.00 $ | +140.6 % | +444.0 % | +529.6 % | −4.8 % | -5.0 % | 98 | 50 | 12.4 % | 11.1 % | 2.43 | — | 0.0 | — | — | — | — | -1.7 | 0.0 % | — | 0.0 % | -43.6 % | -25.5 % | — | 94.1 % | -100.0 % | — | 0.0 % | 0.0 % | 16.0 | 27.6 % | 32.4 % | 1.0 (3) | |
| ATROB Astronics Corp Cl B | 07/30 | +130 % | — | Stage 2 | B 60 | 6 of 9 | 0.0 $ | Aerospace & Defense | – | — | — | Industrials | 69.00 $ | +81.9 % | +204.6 % | +129.1 % | −9.8 % | — | 98 | 50 | 9.3 % | 6.4 % | 1.13 | 82.6 | 27.1 | — | 25.7 | — | 1.45 | 34.3 | — | 31.4 % | 5.1 % | 21.2 % | 9.0 % | 2.34 | — | +8.4 % | — | 0.0 % | 0.0 % | 7.9 | 11.0 % | — | — |
| ARTV Artiva Biotherapeutics, Inc. Common Stock | 08/05 | — | 70 6/22 | Stage 2 | E 20 | 2 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 10.10 $ | +128.4 % | +122.8 % | +236.7 % | −39.2 % | +254.5 % | 98 | 42 | 10.4 % | 10.4 % | 2.19 | — | 0.0 | — | 6.1 | — | — | 0.0 | — | — | 0.0 % | -67.9 % | -38.7 % | 0.12 | — | -100.0 % | — | 0.0 % | 0.0 % | -3.3 | 51.3 % | 5.1 % | 4.7 (6) |
| WYY WidePoint Corporation | 08/13 | +242 % | 92 10/25 | Stage 2 | C 52 | 5 of 9 | 0.1 $ | Information Technology Services | – | — | — | Technology | 10.20 $ | +184.4 % | +194.6 % | +237.9 % | −16.9 % | -3.5 % | 98 | 13 | 16.8 % | 12.9 % | 1.71 | — | 18.2 | 0.6 | — | 13.0 | 2.33 | 117.4 | — | 13.9 % | -1.2 % | -15.8 % | -1.6 % | — | — | +5.6 % | — | 0.0 % | 0.0 % | -0.1 | 18.7 % | 3.5 % | — |
| RVMD Revolution Medicines Inc | 08/05 | +188 % | 38 4/22 | Stage 2 | D 41 | 1 of 9 | 39.0 $ | Biotechnology | – | — | — | Healthcare | 187.50 $ | +112.8 % | +137.2 % | +403.2 % | −3.4 % | +10.4 % | 97 | 42 | 4.8 % | 4.4 % | 1.38 | — | 0.0 | — | 27.2 | — | — | -9.7 | 0.0 % | -151,691.8 % | 0.0 % | -76.7 % | -37.5 % | 0.29 | 66.6 % | -100.0 % | — | 0.0 % | 0.0 % | 1.4 | 95.7 % | 7.0 % | 4.7 (12) |
| KLIC Kulicke and Soffa Industries Inc | 08/05 | +47 % | 60 6/25 | Stage 2 | B 64 | 6 of 9 | 4.7 $ | Semiconductor Equipment & Materials | Neutral | — | Technology | 89.20 $ | +180.3 % | +179.3 % | +176.2 % | −1.4 % | +12.1 % | 97 | 6 | 7.6 % | 6.8 % | 1.63 | 81.7 | 20.8 | 6.1 | 5.4 | 1,085.3 | 2.38 | 48.1 | 15.9 % | 49.8 % | 7.2 % | 6.4 % | 3.9 % | 0.05 | 72.3 % | -7.4 % | — | 0.9 % | 54.3 % | 13.9 | 93.1 % | 6.1 % | 4.0 (5) | |
| RLAY Relay Therapeutics Inc | 08/06 | +16 % | 88 8/22 | Stage 2 | D 27 | 3 of 9 | 4.1 $ | Biotechnology | – | — | — | Healthcare | 18.80 $ | +106.1 % | +128.2 % | +434.9 % | −5.9 % | +38.7 % | 97 | 42 | 6.4 % | 8.1 % | 1.68 | — | 0.0 | 379.8 | — | — | — | -0.8 | -2,619.7 % | -2,300.3 % | 0.0 % | -40.0 % | -24.7 % | — | 91.8 % | +53.4 % | — | 0.0 % | 0.0 % | 8.5 | 87.0 % | 22.8 % | 4.3 (13) |
| MBX MBX Biosciences, Inc. | 08/06 | — | 69 6/22 | Stage 2 | D 34 | 3 of 9 | 3.0 $ | Biotechnology | Neutral | — | Healthcare | 65.90 $ | +47.1 % | +67.7 % | +397.6 % | −4.1 % | +22.0 % | 97 | 42 | 8.5 % | 7.7 % | — | — | 0.0 | — | 7.2 | — | — | 0.0 | 0.0 % | — | 0.0 % | -25.7 % | -17.7 % | 0.00 | 96.7 % | — | — | 0.0 % | 0.0 % | 37.2 | 111.5 % | 17.0 % | 4.6 (5) | |
| ATEX Anterix Inc | 08/11 | +51 % | 89 9/24 | Stage 2 | A 78 | 7 of 9 | 1.8 $ | Telecom Services | Neutral | — | Communication Services | 93.00 $ | +266.4 % | +339.9 % | +318.8 % | −8.1 % | +15.8 % | 97 | 85 | 8.3 % | 8.2 % | 0.83 | 21.3 | 0.0 | 266.2 | 7.7 | 319.5 | — | -12.4 | — | 100.0 % | 1,394.2 % | 43.3 % | -6.5 % | 0.02 | — | +7.8 % | — | 0.0 % | 0.0 % | 3.5 | 91.8 % | 16.9 % | 4.7 (3) | |
| BIOA BioAge Labs, Inc | 08/05 | — | — | Stage 2 | C 49 | 4 of 9 | 0.0 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 9.00 $ | +68.7 % | +77.2 % | +105.5 % | −9.3 % | +118.8 % | 97 | 50 | 8.5 % | 7.7 % | — | — | 0.0 | — | 1.2 | — | — | 0.0 | — | -707.2 % | 0.0 % | -26.0 % | -17.2 % | 0.01 | — | -100.0 % | — | 0.0 % | 0.0 % | 26.5 | 85.5 % | 5.1 % | — |
| APLD Applied Digital Corporation | 07/29 | +153 % | 60 6/25 | Stage 2 | C 52 | 5 of 9 | 8.1 $ | Information Technology Services | Sells AI | — | Technology | 27.40 $ | +84.6 % | +46.9 % | +108.5 % | −19.3 % | +170.6 % | 96 | 42 | 8.8 % | 9.9 % | 5.68 | — | 526.3 | — | 5.0 | — | 1.83 | -7.4 | -20.5 % | 25.9 % | -39.9 % | -5.6 % | -1.8 % | 1.79 | 25.3 % | +57.7 % | — | 0.0 % | 0.0 % | 4.7 | 71.9 % | 26.5 % | 4.4 (9) | |
| APGE Apogee Therapeutics, Inc. | 08/10 | — | 68 6/22 | Stage 2 | D 35 | 4 of 9 | 10.1 $ | Biotechnology | – | — | — | Healthcare | 134.10 $ | +76.0 % | +69.8 % | +250.5 % | −0.4 % | -2.7 % | 96 | 42 | 6.7 % | 6.5 % | 0.33 | — | 0.0 | — | 8.0 | — | — | 0.0 | 0.0 % | — | 0.0 % | -28.5 % | -19.0 % | 0.01 | 97.1 % | — | — | 0.0 % | 0.0 % | 40.3 | 131.6 % | 7.0 % | 5.0 (9) |
| TVTX Travere Therapeutics Inc | 08/05 | +82 % | 68 6/22 | Stage 2 | B 64 | 5 of 9 | 5.1 $ | Biotechnology | Uses AI | — | Healthcare | 55.90 $ | +46.4 % | +44.7 % | +261.8 % | −1.8 % | +5.8 % | 96 | 42 | 3.6 % | 4.6 % | 1.11 | — | 76.3 | 9.5 | 51.5 | 292.4 | — | 136.5 | -29.0 % | 56.0 % | -4.0 % | -69.4 % | -6.5 % | 3.35 | 17.8 % | +110.5 % | — | 0.0 % | 0.0 % | -2.7 | 113.4 % | 16.9 % | 4.6 (15) | |
| CELC Celcuity LLC | 08/13 | +65 % | 80 7/22 | Stage 1 | C 47 | 2 of 9 | 4.3 $ | Biotechnology | Neutral | — | — | Healthcare | 86.40 $ | -9.6 % | -0.1 % | +120.6 % | −36.5 % | +89.3 % | 96 | 42 | 5.5 % | 7.2 % | 0.16 | — | 0.0 | 21,410.0 | — | — | — | -7.8 | 0.0 % | — | 0.0 % | -275.2 % | -37.1 % | — | 13.1 % | — | — | 0.0 % | 0.0 % | 2.6 | 101.2 % | 34.4 % | 4.7 (7) |
| DNTH Dianthus Therapeutics Inc. | 08/06 | +247 % | — | Stage 2 | D 37 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 106.90 $ | +112.4 % | +121.7 % | +417.3 % | −5.1 % | +39.4 % | 96 | 50 | 5.9 % | 6.6 % | 0.09 | — | 0.0 | — | — | — | — | -7.3 | -10,050.3 % | 100.0 % | 0.0 % | -22.7 % | -15.0 % | — | 96.4 % | -67.4 % | — | 0.0 % | 0.0 % | 35.6 | 120.4 % | 14.7 % | 1.0 (12) |
| GLUE Monte Rosa Therapeutics Inc | 08/06 | +19 % | — | Stage 2 | D 35 | 4 of 9 | 0.0 $ | Biotechnology | Uses AI | — | Healthcare | 16.50 $ | +32.1 % | +35.5 % | +233.7 % | −16.0 % | +53.1 % | 96 | 50 | 8.1 % | 6.8 % | 1.56 | — | 10.9 | — | 2.5 | — | — | 51.9 | — | -238.5 % | 0.0 % | -32.6 % | -16.4 % | 0.08 | — | +63.5 % | — | 0.0 % | 0.0 % | 7.7 | 113.2 % | 20.7 % | — | |
| TH Target Hospitality Corp. | 08/06 | +18 % | 96 13/29 | Stage 2 | D 37 | 4 of 9 | 1.5 $ | Specialty Business Services | Sells AI | — | Industrials | 15.20 $ | +101.6 % | +110.8 % | +100.3 % | −21.3 % | +49.7 % | 96 | 12 | 4.0 % | 4.1 % | 1.46 | — | 20.2 | 4.7 | 4.0 | 57.5 | 1.34 | 57.1 | -19.7 % | 28.0 % | -13.5 % | -11.0 % | -5.0 % | 0.02 | 73.4 % | -17.0 % | — | 0.0 % | 0.0 % | 8.0 | 78.5 % | 12.3 % | 3.7 (3) | |
| IRWD Ironwood Pharmaceuticals Inc | 08/06 | -22 % | 56 5/22 | Stage 2 | B 60 | 6 of 9 | 0.7 $ | Drug Manufacturers - Specialty & Generic | Neutral | — | Healthcare | 4.20 $ | +14.5 % | +31.9 % | +453.7 % | −33.6 % | +51.2 % | 96 | 97 | 6.0 % | 6.0 % | 0.21 | 7.3 | 12.3 | 1.9 | 2.8 | 6.1 | — | 5.2 | — | 75.2 % | 28.3 % | -574.7 % | 33.2 % | -2.75 | — | -15.7 % | — | 0.0 % | 0.0 % | -4.7 | 98.9 % | 11.4 % | 3.0 (4) | |
| BLZE Backblaze Inc | 08/06 | +57 % | 62 6/25 | Stage 3 | B 58 | 5 of 9 | 0.8 $ | Software - Infrastructure | Uses AI | — | Technology | 13.70 $ | +150.2 % | +211.9 % | +175.0 % | −8.2 % | +10.7 % | 96 | 42 | 14.6 % | 9.7 % | 1.55 | — | 158.7 | 5.2 | — | 57.1 | — | 131.6 | — | 62.3 % | -15.0 % | -27.6 % | -5.2 % | — | — | +14.3 % | — | 0.0 % | 0.0 % | -0.3 | 48.9 % | 4.5 % | 4.8 (6) | |
| DWSN Dawson Geophysical Company | 08/11 | +12 % | 57 2/10 | Stage 2 | B 65 | 5 of 9 | 0.1 $ | Oil & Gas Equipment & Services | – | — | — | Energy | 4.70 $ | +192.9 % | +232.9 % | +221.4 % | −2.0 % | -17.5 % | 96 | 96 | 9.5 % | 10.2 % | -0.07 | — | 3.8 | 1.5 | — | 41.4 | 12.17 | 16.8 | — | 22.7 % | 4.9 % | 22.7 % | 7.6 % | — | — | +2.0 % | — | 0.0 % | 0.0 % | -2.2 | 86.1 % | 1.2 % | — |
| IMMX Immix Biopharma Inc | 08/14 | +93 % | 89 8/22 | Stage 2 | D 38 | 5 of 9 | 0.6 $ | Biotechnology | – | — | — | Healthcare | 8.30 $ | +89.5 % | +82.8 % | +205.9 % | −16.3 % | +139.9 % | 96 | 42 | 9.2 % | 8.4 % | 0.09 | — | 0.0 | — | 7.2 | — | — | -0.4 | — | — | 0.0 % | -74.5 % | -39.0 % | 0.01 | — | — | — | 0.0 % | 0.0 % | 10.2 | 45.1 % | 14.4 % | 4.0 (1) |
| MGNX MacroGenics Inc | 08/13 | -6 % | 94 9/22 | Stage 2 | D 38 | 5 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 3.70 $ | +191.3 % | +200.0 % | +136.5 % | −8.3 % | +44.8 % | 96 | 8 | 8.1 % | 7.0 % | 1.18 | — | 61.0 | 1.5 | — | — | 0.01 | 5.6 | — | -16.2 % | -44.8 % | -140.3 % | -18.0 % | — | — | +0.8 % | — | 0.0 % | 0.0 % | -15.0 | 70.3 % | 7.8 % | — |
| RIOT Riot Platforms, Inc. | 07/30 | +49 % | 78 7/22 | Stage 2 | D 31 | 2 of 9 | 7.7 $ | Capital Markets | Sells AI | — | Financial Services | 20.20 $ | +126.4 % | +99.4 % | +50.4 % | −8.4 % | +46.9 % | 95 | 74 | 7.9 % | 7.5 % | 3.81 | — | 20.9 | 11.8 | 3.2 | — | — | 11.4 | -280.5 % | 32.4 % | -132.8 % | -32.5 % | -12.1 % | 0.39 | 69.7 % | +71.9 % | — | 0.0 % | 0.0 % | 3.1 | 81.6 % | 15.3 % | 4.5 (16) | |
| SPHR Sphere Entertainment Co. | 08/06 | +158 % | — | Stage 2 | C 48 | 9 of 9 | 0.0 $ | Entertainment | Uses AI | — | Communication Services | 143.30 $ | +66.4 % | +83.4 % | +232.8 % | −0.4 % | +5.6 % | 95 | 50 | 4.7 % | 4.8 % | 1.60 | 58.5 | 28.4 | — | 2.8 | — | — | 11.6 | 2.7 % | 55.1 % | 8.6 % | 5.5 % | -1.0 % | 0.42 | 53.2 % | +0.0 % | — | 0.0 % | 0.0 % | 4.9 | 130.0 % | 37.2 % | 1.5 (10) | |
| ATRO Astronics Corporation | 08/05 | +154 % | 76 9/29 | Stage 2 | B 56 | 6 of 9 | 3.4 $ | Aerospace & Defense | Neutral | — | Industrials | 69.50 $ | +91.0 % | +94.2 % | +141.1 % | −12.8 % | +14.4 % | 95 | 89 | 6.0 % | 5.8 % | 1.13 | — | 27.2 | 3.8 | — | 136.9 | 1.46 | 33.6 | 11.8 % | 31.4 % | 5.1 % | 21.2 % | 9.0 % | — | 21.6 % | +8.4 % | — | 0.0 % | 0.0 % | 7.9 | 101.1 % | 8.0 % | 3.3 (3) | |
| ELVN Enliven Therapeutics Inc. | 08/12 | +44 % | 69 6/22 | Stage 2 | D 29 | 4 of 9 | 3.7 $ | Biotechnology | – | — | — | Healthcare | 54.80 $ | +215.6 % | +203.9 % | +191.4 % | −2.8 % | +22.1 % | 95 | 42 | 6.6 % | 6.9 % | 0.26 | — | 0.0 | — | 8.8 | — | — | -6.3 | 0.0 % | — | 0.0 % | -26.6 % | -18.9 % | 0.00 | 97.5 % | — | — | 0.0 % | 0.0 % | 47.0 | 89.7 % | 17.7 % | 4.9 (8) |
| CAPR Capricor Therapeutics Inc | 08/10 | +8 % | 69 6/22 | Stage 2 | E 24 | 3 of 9 | 1.0 $ | Biotechnology | Neutral | — | Healthcare | 3.90 $ | +2.6 % | -19.8 % | -52.9 % | −24.7 % | +12.2 % | 95 | 42 | 7.5 % | 5.7 % | 0.42 | — | 78.7 | — | — | — | 0.38 | -2.7 | 0.0 % | -834.8 % | 0.0 % | -56.4 % | -31.2 % | — | 85.4 % | -100.0 % | — | 0.0 % | 0.0 % | 8.7 | 59.7 % | 29.7 % | 4.6 (8) | |
| VSTS Vestis Corporation | 08/04 | — | 76 9/29 | Stage 2 | C 45 | 8 of 9 | 1.9 $ | Rental & Leasing Services | – | — | — | Industrials | 14.50 $ | +97.9 % | +120.0 % | +138.6 % | −2.0 % | -28.3 % | 95 | 3 | 3.9 % | 4.3 % | 1.15 | — | 0.0 | 0.7 | — | 19.5 | — | 15.3 | 4.2 % | 26.1 % | -0.6 % | -2.0 % | 2.2 % | — | 30.2 % | -2.5 % | — | 0.0 % | 0.0 % | 4.9 | 101.7 % | 8.9 % | 3.3 (9) |
| APPS Digital Turbine Inc | 08/04 | -13 % | 92 10/25 | Stage 2 | B 65 | 6 of 9 | 1.0 $ | Software - Application | Uses AI | — | Technology | 8.10 $ | +85.2 % | +140.0 % | +47.9 % | −5.9 % | +35.8 % | 95 | 17 | 10.7 % | 12.7 % | 2.77 | — | 200.0 | 1.8 | — | 88.3 | 0.69 | 12.4 | — | 48.6 % | -6.7 % | -21.8 % | 2.6 % | — | — | +15.2 % | — | 0.0 % | 0.0 % | 0.9 | 66.7 % | 9.1 % | 3.5 (2) | |
| NVCT Nuvectis Pharma Inc | 08/04 | +1 % | 82 7/22 | Stage 2 | E 24 | 1 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 21.50 $ | +132.5 % | +270.0 % | +209.2 % | −0.2 % | +47.9 % | 95 | 42 | 16.4 % | 9.8 % | -0.25 | — | 0.0 | — | — | — | — | -7.4 | — | — | 0.0 % | -154.4 % | -63.6 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -7.1 | 18.2 % | 7.3 % | 4.3 (6) |
| ZNTL Zentalis Pharmaceuticals Llc | 08/05 | -29 % | 71 6/22 | Stage 2 | D 26 | 2 of 9 | 0.3 $ | Biotechnology | – | — | — | Healthcare | 4.70 $ | +172.6 % | +234.1 % | +243.5 % | −45.5 % | +41.8 % | 95 | 42 | 8.9 % | 7.8 % | 1.93 | — | 0.0 | — | — | — | — | -2.3 | — | 100.0 % | 0.0 % | -51.9 % | -27.9 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -8.6 | 62.1 % | 10.8 % | 3.7 (10) |
| SNX Synnex Corporation | — | +71 % | 34 4/25 | Stage 2 | B 65 | 5 of 9 | 20.7 $ | Electronics & Computer Distribution | Sells AI | — | Technology | 255.70 $ | +94.2 % | +77.4 % | +78.9 % | −6.4 % | +30.4 % | 94 | 86 | 4.3 % | 4.0 % | 1.43 | 17.6 | 18.3 | 0.3 | 2.3 | 16.5 | 1.15 | 10.7 | 2.7 % | 7.0 % | 1.6 % | 11.7 % | 3.3 % | 0.23 | 23.2 % | +6.9 % | — | 0.8 % | 11.2 % | 5.1 | 95.7 % | 2.4 % | 4.4 (11) | |
| OSCR Oscar Health Inc | 08/05 | +84 % | 79 7/22 | Stage 2 | B 64 | 7 of 9 | 9.0 $ | Healthcare Plans | Uses AI | — | — | Healthcare | 31.20 $ | +108.3 % | +97.3 % | +122.2 % | −5.6 % | -19.2 % | 94 | 87 | 5.6 % | 6.6 % | 2.34 | — | 588.2 | 0.7 | 5.7 | 3.2 | — | 0.0 | 15.2 % | 17.4 % | -0.3 % | -2.6 % | 0.1 % | 0.26 | 17.9 % | +27.5 % | — | 0.0 % | 0.0 % | 3.0 | 67.6 % | 8.0 % | 3.3 (7) |
| XMTR Xometry Inc | 08/04 | +114 % | 66 8/29 | Stage 2 | B 65 | 5 of 9 | 4.7 $ | Industrial Distribution | – | — | — | Industrials | 85.70 $ | +54.3 % | +48.6 % | +165.1 % | −7.3 % | +12.3 % | 94 | 42 | 4.8 % | 5.7 % | 1.27 | — | 111.1 | 6.4 | 16.6 | — | — | -13.1 | -2.5 % | 39.3 % | -7.0 % | -17.5 % | -3.1 % | 1.21 | 38.1 % | +25.9 % | — | 0.0 % | 0.0 % | 3.0 | 96.4 % | 7.0 % | 3.9 (10) |
| IRDM Iridium Communications Inc | 07/23 | -8 % | 84 8/24 | Stage 2 | D 43 | 6 of 9 | 5.0 $ | Telecom Services | Neutral | — | Communication Services | 47.30 $ | +156.4 % | +216.6 % | +98.6 % | −22.3 % | -11.2 % | 94 | 21 | 9.0 % | 8.0 % | 0.88 | 49.7 | 43.9 | 5.7 | 11.1 | 17.4 | 3.37 | 15.6 | 23.2 % | 71.9 % | 10.5 % | 21.4 % | 5.1 % | 4.77 | 18.5 % | +4.9 % | — | 1.3 % | 59.3 % | 4.1 | 90.1 % | 3.1 % | 4.6 (9) | |
| IBRX Immunitybio Inc | 08/04 | +57 % | 56 5/22 | Stage 2 | C 51 | 3 of 9 | 7.4 $ | Biotechnology | Uses AI | — | Healthcare | 7.20 $ | +269.7 % | +309.8 % | +191.5 % | −37.3 % | +77.1 % | 94 | 42 | 7.8 % | 7.0 % | 0.08 | — | 0.0 | 52.7 | — | — | — | -9.0 | -157.9 % | 99.3 % | 0.0 % | 0.0 % | -34.4 % | — | -134.5 % | +668.3 % | — | 0.0 % | 0.0 % | -23.1 | 17.6 % | 34.6 % | 4.6 (5) | |
| NESR National Energy Services Reunited Corp. | 08/19 | +252 % | 56 2/10 | Stage 2 | B 64 | 7 of 9 | 2.7 $ | Oil & Gas Equipment & Services | Neutral | — | Energy | 27.00 $ | +60.1 % | +89.1 % | +304.2 % | −2.6 % | +22.2 % | 94 | 87 | 5.7 % | 5.1 % | 0.32 | 43.3 | 0.0 | 1.9 | 2.7 | 21.7 | — | 11.8 | 8.9 % | 12.5 % | 4.5 % | 6.7 % | 3.8 % | 0.31 | 51.7 % | +1.7 % | — | 0.0 % | 0.0 % | 5.0 | 85.2 % | 6.2 % | 4.3 (3) | |
| URGN UroGen Pharma Ltd | 08/06 | +18 % | 69 6/22 | Stage 2 | B 57 | 3 of 9 | 1.8 $ | Biotechnology | Uses AI | — | — | Healthcare | 38.20 $ | +50.1 % | +51.8 % | +100.6 % | −4.7 % | +17.1 % | 94 | 42 | 5.1 % | 5.4 % | 1.58 | — | 0.0 | 13.1 | — | — | — | -2.6 | -39.8 % | 89.9 % | -94.8 % | -1,481.3 % | -27.0 % | — | -49.0 % | +21.5 % | — | 0.0 % | 0.0 % | -8.0 | 100.6 % | 11.9 % | 4.4 (8) |
| SEPN Septerna, Inc. Common Stock | 08/10 | — | — | Stage 2 | C 48 | 4 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 34.50 $ | +31.2 % | +17.9 % | +177.6 % | −9.1 % | +30.3 % | 94 | 50 | 7.5 % | 6.9 % | — | — | 107.5 | — | — | — | — | 0.0 | — | 100.0 % | -49.9 % | -9.3 % | -8.5 % | — | — | +4,174.5 % | — | 0.0 % | 0.0 % | 7.0 | 102.7 % | 11.7 % | — |
| DSGN Design Therapeutics Inc | 08/06 | +47 % | — | Stage 2 | D 30 | 1 of 9 | 0.0 $ | Biotechnology | – | — | — | Healthcare | 12.20 $ | +46.5 % | +46.2 % | +214.7 % | −22.1 % | +56.3 % | 94 | 50 | 7.3 % | 7.9 % | 1.59 | — | 0.0 | — | — | — | — | -0.8 | — | -176,154.6 % | 0.0 % | -31.3 % | -20.9 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | 21.4 | 62.1 % | 9.8 % | — |
| STRZ Starz Entertainment LLC | — | — | — | Stage 2 | E 19 | 4 of 9 | 0.0 $ | Entertainment | – | — | — | Communication Services | 26.00 $ | +143.2 % | +152.5 % | +78.8 % | −9.7 % | +15.0 % | 94 | 50 | 6.8 % | 7.1 % | — | — | 3.6 | — | — | — | — | 1.7 | — | 50.7 % | -13.2 % | -34.7 % | -0.8 % | — | — | -8.2 % | — | 0.0 % | 0.0 % | 1.3 | 92.3 % | 3.7 % | — |
| TMCI Treace Medical Concepts Inc | 08/06 | -28 % | 40 4/22 | Stage 3 | D 33 | 4 of 9 | 0.2 $ | Medical Devices | Neutral | — | Healthcare | 4.30 $ | +83.3 % | +75.0 % | -19.7 % | −42.8 % | -10.1 % | 94 | 42 | 10.5 % | 9.8 % | 1.38 | — | 0.0 | 1.2 | 3.4 | — | — | -40.9 | — | 79.7 % | -29.4 % | -66.9 % | -17.9 % | 0.18 | — | +1.6 % | — | 0.0 % | 0.0 % | 0.4 | 57.1 % | 6.3 % | — | |
| ACRS Aclaris Therapeutics Inc | 08/06 | -17 % | 41 4/22 | Stage 2 | D 31 | 5 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 5.20 $ | +63.5 % | +65.1 % | +239.9 % | −4.7 % | +92.3 % | 94 | 42 | 5.9 % | 5.5 % | 0.77 | — | 0.0 | 85.6 | — | — | — | 0.3 | — | -668.2 % | 0.0 % | -48.4 % | -24.7 % | — | — | -58.2 % | — | 0.0 % | 0.0 % | -9.9 | 79.7 % | 10.9 % | 4.3 (6) |
| AVR Anteris Technologies Global Corp. Common Stock | 08/10 | — | 70 6/22 | Stage 2 | D 31 | 4 of 9 | 0.8 $ | Medical Instruments & Supplies | – | — | — | Healthcare | 7.80 $ | +106.0 % | +80.8 % | +144.2 % | −6.4 % | +96.6 % | 94 | 42 | 6.4 % | 6.9 % | 0.73 | — | 0.0 | 421.7 | — | — | — | 0.0 | — | 74.3 % | 0.0 % | -59.2 % | -34.0 % | — | — | -29.2 % | — | 0.0 % | 0.0 % | 20.7 | 66.1 % | 11.9 % | 4.8 (4) |
| LCUT Lifetime Brands Inc | 08/06 | +27 % | 65 8/31 | Stage 2 | D 43 | 5 of 9 | 0.2 $ | Furnishings, Fixtures & Appliances | – | — | — | Consumer Cyclical | 8.40 $ | +117.0 % | +138.9 % | +99.2 % | −14.7 % | -0.3 % | 94 | 86 | 9.0 % | 9.0 % | 0.98 | — | 12.6 | 0.3 | — | 10.6 | 0.90 | 46.1 | — | 37.5 % | -4.2 % | -13.0 % | 1.6 % | — | — | -5.1 % | — | 2.0 % | 24.3 % | 6.0 | 68.2 % | 3.8 % | — |
| RCUS Arcus Biosciences Inc | 08/05 | +16 % | 40 4/22 | Stage 2 | D 34 | 0 of 9 | 3.5 $ | Biotechnology | Neutral | — | Healthcare | 28.20 $ | +18.3 % | +34.4 % | +208.8 % | −3.8 % | +30.6 % | 93 | 42 | 6.2 % | 6.0 % | 0.80 | — | 0.0 | 15.0 | 6.9 | — | — | 4.0 | -788.2 % | -121.6 % | -156.4 % | -70.0 % | -23.1 % | 0.22 | 52.6 % | -4.3 % | — | 0.0 % | 0.0 % | 1.0 | 72.4 % | 16.4 % | 4.5 (13) | |
| TSHA Taysha Gene Therapies Inc | 08/11 | +87 % | — | Stage 2 | D 35 | 4 of 9 | 0.0 $ | Biotechnology | Neutral | — | Healthcare | 5.90 $ | +24.7 % | +13.9 % | +114.7 % | −14.9 % | +109.3 % | 93 | 50 | 7.2 % | 6.9 % | 1.16 | — | 0.0 | — | — | — | — | -0.6 | -1,774.4 % | 100.0 % | 0.0 % | -97.3 % | -37.8 % | — | 70.6 % | +17.3 % | — | 0.0 % | 0.0 % | 0.4 | 95.8 % | 13.7 % | 1.0 (10) | |
| CORZ Core Scientific, Inc. | 08/14 | — | 46 5/25 | Stage 2 | D 44 | 4 of 9 | 6.6 $ | Software - Infrastructure | – | — | — | Technology | 20.70 $ | +100.3 % | +66.6 % | +53.0 % | −10.5 % | +79.3 % | 93 | 80 | 6.3 % | 6.5 % | 5.50 | — | 166.7 | 14.9 | 0.0 | — | — | 454.9 | -18.8 % | 32.1 % | 0.0 % | 0.0 % | -2.4 % | -1.57 | -42.5 % | -37.5 % | — | 0.0 % | 0.0 % | -5.1 | 124.5 % | 22.6 % | 4.7 (16) |
| GSAT Globalstar, Inc. Common Stock | 08/06 | +150 % | 89 9/24 | Stage 2 | D 39 | 5 of 9 | 10.7 $ | Telecom Services | – | — | — | Communication Services | 83.40 $ | +30.9 % | +28.3 % | +255.0 % | −5.6 % | +7.9 % | 93 | 42 | 1.5 % | 1.5 % | 1.54 | — | 9.2 | 38.0 | 31.3 | 556.5 | 0.50 | 101.1 | 16.3 % | 63.7 % | -3.1 % | -2.5 % | 0.8 % | 1.54 | 14.4 % | +9.0 % | — | 0.0 % | 0.0 % | 1.0 | 26.3 % | 6.3 % | 4.3 (3) |
| LASR nLIGHT Inc | 08/06 | +113 % | 73 7/25 | Stage 2 | B 72 | 7 of 9 | 3.9 $ | Semiconductors | – | — | — | Technology | 68.80 $ | +77.1 % | +65.4 % | +227.5 % | −28.2 % | +31.9 % | 93 | 42 | 7.4 % | 8.0 % | 2.30 | — | 135.1 | 13.4 | 8.9 | 175.7 | 1.78 | 3,043.3 | -0.5 % | 31.3 % | -5.1 % | -4.6 % | -2.3 % | 0.08 | 83.2 % | +31.6 % | — | 0.0 % | 0.0 % | 11.0 | 92.1 % | 5.2 % | 4.6 (7) |
| CGEM Cullinan Oncology LLC | 08/06 | +14 % | 55 5/22 | Stage 2 | C 47 | 1 of 9 | 1.0 $ | Biotechnology | – | — | — | Healthcare | 16.50 $ | +71.5 % | +79.5 % | +112.4 % | −1.5 % | +91.7 % | 93 | 42 | 8.3 % | 8.2 % | -0.01 | — | 6.7 | — | — | — | — | -1.5 | — | — | 0.0 % | -48.2 % | -30.6 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | 10.2 | 107.8 % | 23.8 % | 4.9 (9) |
| JBIO Jade Biosciences, Inc. | 08/12 | -21 % | 55 5/22 | Stage 2 | E 24 | 2 of 9 | 1.1 $ | Biotechnology | – | — | — | Healthcare | 19.80 $ | +42.4 % | +33.8 % | +174.7 % | −22.1 % | +144.9 % | 93 | 42 | 9.6 % | 9.1 % | — | — | 0.0 | — | 4.1 | — | — | 0.0 | — | — | 0.0 % | -89.2 % | -33.6 % | 0.00 | — | — | — | 0.0 % | 0.0 % | 18.0 | 84.8 % | 15.3 % | 5.0 (3) |
| WEST Westrock Coffee Company | 08/06 | -6 % | — | Stage 2 | D 41 | 3 of 9 | 0.0 $ | Packaged Foods | – | — | — | Consumer Defensive | 8.10 $ | +123.1 % | +98.3 % | +22.1 % | −2.4 % | -8.8 % | 93 | 50 | 7.4 % | 6.7 % | 0.90 | — | 0.0 | — | — | — | — | 44.0 | — | 13.0 % | -5.6 % | -24.0 % | -0.9 % | — | — | +39.8 % | — | 0.0 % | 0.0 % | 1.8 | 49.5 % | 13.2 % | — |
| FATE Fate Therapeutics Inc | 08/11 | -19 % | 40 4/22 | Stage 2 | D 26 | 2 of 9 | 0.3 $ | Biotechnology | – | — | — | Healthcare | 2.50 $ | +119.8 % | +139.6 % | +122.7 % | −35.1 % | +189.4 % | 93 | 42 | 12.1 % | 11.5 % | 2.52 | — | 0.0 | 46.0 | — | — | — | -2.6 | — | -1,284.8 % | 0.0 % | -55.5 % | -25.3 % | — | — | -51.2 % | — | 0.0 % | 0.0 % | -12.5 | 72.8 % | 10.5 % | — |
| CCCC C4 Therapeutics Inc | 08/06 | -23 % | 57 5/22 | Stage 2 | D 37 | 4 of 9 | 0.4 $ | Biotechnology | – | — | — | Healthcare | 3.50 $ | +120.9 % | +109.1 % | +69.8 % | −4.3 % | +281.0 % | 93 | 42 | 7.7 % | 9.3 % | 2.91 | — | 0.0 | 11.4 | 1.7 | — | — | -0.4 | — | 78.3 % | -297.8 % | -48.4 % | -19.9 % | 0.25 | — | +1.0 % | — | 0.0 % | 0.0 % | 0.5 | 85.1 % | 21.7 % | 4.0 (8) |
| GH Guardant Health Inc | 07/29 | +89 % | 78 7/22 | Stage 2 | B 55 | 6 of 9 | 21.5 $ | Diagnostics & Research | Sells AI | — | Healthcare | 162.00 $ | +28.1 % | +50.2 % | +295.3 % | −2.0 % | +15.7 % | 92 | 42 | 5.3 % | 5.7 % | 1.59 | — | 0.0 | 18.2 | 63.1 | — | — | -5.4 | -40.2 % | 65.0 % | -38.3 % | -4,584.5 % | -18.1 % | -6.60 | -9.5 % | +32.9 % | — | 0.0 % | 0.0 % | 0.1 | 106.0 % | 9.0 % | 4.7 (23) | |
| INSW International Seaways Inc | 08/05 | +79 % | 79 3/10 | Stage 2 | B 63 | 7 of 9 | 4.7 $ | Oil & Gas Midstream | – | — | — | Energy | 96.20 $ | +102.2 % | +76.8 % | +171.9 % | −12.1 % | -3.3 % | 92 | 95 | 5.0 % | 4.2 % | -0.10 | — | 7.0 | 4.8 | — | 38.6 | — | 6.7 | 61.3 % | 67.7 % | 55.3 % | 26.9 % | 10.5 % | — | 76.4 % | -11.4 % | — | 4.1 % | 111.1 % | 11.0 | 80.8 % | 6.2 % | 4.8 (6) |
| MRX Marex Group plc Ordinary Shares | 08/12 | — | 79 7/22 | Stage 2 | B 61 | 4 of 9 | 4.6 $ | Capital Markets | – | — | — | Financial Services | 64.90 $ | +74.6 % | +49.3 % | +70.9 % | −4.8 % | +11.5 % | 92 | 79 | 4.9 % | 4.7 % | -0.09 | 14.7 | 8.8 | 0.8 | 3.5 | — | — | 6.1 | 13.1 % | 68.9 % | 10.6 % | 29.1 % | 1.1 % | — | 3.7 % | +25.4 % | — | 1.0 % | 17.1 % | 4.2 | 75.2 % | 5.1 % | 4.3 (8) |
| NAT Nordic American Tankers Limited | — | +50 % | 98 5/10 | Stage 2 | C 54 | 7 of 9 | 1.3 $ | Oil & Gas Midstream | – | — | — | Energy | 6.50 $ | +102.0 % | +83.4 % | +169.1 % | −6.6 % | -7.7 % | 92 | 97 | 5.9 % | 4.4 % | -0.55 | — | 14.0 | 3.9 | — | — | 1.21 | 18.9 | 49.5 % | 46.9 % | 16.4 % | 11.4 % | 4.7 % | — | 50.6 % | -16.4 % | — | 13.5 % | 2.8 % | 6.0 | 50.0 % | 8.2 % | 3.7 (3) |
| ETON Eton Pharmaceuticals Inc | 08/06 | +249 % | 96 10/22 | Stage 2 | B 55 | 7 of 9 | 1.3 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 46.40 $ | +98.0 % | +116.2 % | +227.8 % | −2.4 % | +18.0 % | 92 | 26 | 4.8 % | 5.7 % | 0.86 | — | 52.6 | 14.7 | 42.5 | 82.9 | — | 206.8 | — | 59.7 % | -1.7 % | -5.4 % | 4.8 % | 0.40 | — | +104.9 % | — | 0.0 % | 0.0 % | 0.7 | 65.4 % | 6.3 % | 4.7 (3) |
| RAPP Rapport Therapeutics, Inc. | 08/06 | — | 55 5/22 | Stage 2 | D 33 | 4 of 9 | 1.9 $ | Biotechnology | – | — | — | Healthcare | 41.00 $ | +28.1 % | +30.6 % | +185.4 % | −8.0 % | +42.9 % | 92 | 42 | 6.0 % | 6.1 % | 0.95 | — | 0.0 | 96.4 | 4.2 | — | — | 0.0 | — | 34.3 % | 0.0 % | -28.3 % | -19.1 % | 0.02 | — | — | — | 0.0 % | 0.0 % | 25.1 | 109.6 % | 8.9 % | 4.8 (5) |
| ULCC Frontier Group Holdings Inc | 08/04 | -7 % | 49 6/29 | Stage 2 | D 41 | 3 of 9 | 1.5 $ | Airlines | – | — | — | Industrials | 6.80 $ | +53.9 % | +55.0 % | +54.1 % | −4.1 % | -0.3 % | 92 | 52 | 7.3 % | 7.6 % | 2.57 | — | 13.9 | 0.4 | 6.5 | — | — | 100.0 | — | 0.5 % | -9.3 % | -92.4 % | -5.3 % | 23.64 | — | -1.4 % | — | 0.0 % | 0.0 % | 1.7 | 55.2 % | 40.8 % | 3.0 (12) |
| IMUX Immunic Inc | 08/06 | +0 % | 70 6/22 | Stage 2 | D 28 | 5 of 9 | 0.2 $ | Biotechnology | – | — | — | Healthcare | 14.00 $ | +182.2 % | +163.9 % | +48.6 % | −4.4 % | +196.4 % | 92 | 42 | 6.7 % | 8.8 % | 1.38 | — | 0.0 | — | — | — | — | 0.2 | — | — | 0.0 % | -142.9 % | -65.2 % | — | — | -100.0 % | — | 0.0 % | 0.0 % | -2.1 | 46.9 % | 12.7 % | — |
| ROIV Roivant Sciences Ltd | 08/10 | +76 % | 38 4/22 | Stage 2 | D 44 | 3 of 9 | 23.7 $ | Biotechnology | Uses AI | — | — | Healthcare | 33.90 $ | +48.4 % | +54.4 % | +198.5 % | −1.9 % | +14.8 % | 91 | 2 | 3.9 % | 4.0 % | 1.11 | — | 0.0 | 2,857.0 | 5.4 | — | — | 0.7 | -14,675.1 % | -8,159.0 % | 0.0 % | -7.6 % | -14.4 % | 0.02 | 79.0 % | -71.6 % | — | 0.0 % | 0.0 % | 19.2 | 75.9 % | 6.7 % | 4.5 (10) |
| TIGO Millicom International Cellular SA | 08/06 | +180 % | 97 11/24 | Stage 2 | B 62 | 4 of 9 | 16.1 $ | Telecom Services | Neutral | — | Communication Services | 95.50 $ | +64.9 % | +77.5 % | +160.2 % | −6.6 % | -7.4 % | 91 | 17 | 4.6 % | 4.5 % | 0.89 | 13.2 | 19.7 | 2.5 | 5.2 | 11.6 | 0.75 | 7.3 | 21.8 % | 77.1 % | 19.1 % | 37.4 % | 5.8 % | 3.74 | 15.1 % | +0.3 % | — | 3.1 % | 1.7 % | 4.0 | 46.2 % | 5.2 % | 4.3 (10) | |
| KGS Kodiak Gas Services, Inc. | 08/05 | — | 98 5/10 | Stage 2 | B 56 | 7 of 9 | 5.8 $ | Oil & Gas Equipment & Services | – | — | — | Energy | 58.70 $ | +94.9 % | +106.1 % | +89.8 % | −4.8 % | +42.3 % | 91 | 17 | 4.1 % | 3.8 % | 0.82 | 73.8 | 26.0 | 4.4 | 5.1 | 29.2 | — | 15.3 | 33.7 % | 64.2 % | 5.1 % | 5.4 % | 6.0 % | 0.06 | 26.1 % | +12.8 % | — | 3.3 % | 1.8 % | 4.2 | 91.3 % | 9.5 % | 4.4 (11) |
| DHC Diversified Healthcare Trust | 08/03 | +127 % | 44 4/21 | Stage 2 | D 41 | 4 of 9 | 2.1 $ | REIT - Healthcare Facilities | Uses AI | — | — | Real Estate | 8.90 $ | +89.0 % | +97.1 % | +174.0 % | −0.5 % | +11.0 % | 91 | 9 | 4.3 % | 4.0 % | 2.27 | — | 16.6 | 1.4 | 1.3 | — | 1.89 | 50.9 | -1.3 % | 17.7 % | -21.1 % | -17.9 % | -0.5 % | 1.49 | 38.0 % | +2.8 % | — | 0.5 % | 2.3 % | 1.6 | 84.3 % | 5.8 % | 3.3 (3) |
| GHM Graham Corporation | 08/04 | +251 % | — | Stage 2 | C 54 | 1 of 9 | 0.0 $ | Specialty Industrial Machinery | – | — | — | Industrials | 95.90 $ | +70.9 % | +69.7 % | +67.8 % | −1.0 % | +6.4 % | 91 | 50 | 6.2 % | 6.7 % | 1.01 | — | 58.8 | — | — | — | 3.26 | 59.6 | 1.3 % | 23.6 % | 5.1 % | 9.6 % | 3.4 % | — | 43.4 % | +16.9 % | — | 0.0 % | 0.0 % | 5.4 | 80.2 % | 4.6 % | 1.2 (5) |
| LIND Lindblad Expeditions Holdings Inc | 08/03 | +50 % | 43 6/31 | Stage 2 | B 66 | 8 of 9 | 2.0 $ | Travel Services | – | — | — | Consumer Cyclical | 29.60 $ | +78.7 % | +94.4 % | +147.5 % | −1.1 % | -4.7 % | 91 | 94 | 5.8 % | 5.4 % | 2.23 | — | 243.9 | 2.4 | 165.4 | 23.5 | — | 24.5 | 7.5 % | 46.0 % | -3.1 % | -1,946.9 % | 3.8 % | -3.50 | -19.3 % | +19.6 % | — | 0.0 % | 0.0 % | 1.3 | 75.0 % | 11.6 % | 4.3 (3) |
| OMER Omeros Corporation | 08/13 | -8 % | 80 7/22 | Stage 1 | B 66 | 6 of 9 | 0.9 $ | Biotechnology | – | — | — | Healthcare | 11.80 $ | -39.0 % | -35.5 % | +205.9 % | −39.3 % | +179.7 % | 91 | 42 | 10.1 % | 8.1 % | 2.55 | 8.4 | 58.1 | 86.5 | 9.3 | — | 0.81 | -1.5 | — | -190.5 % | 871.0 % | -576.3 % | -25.2 % | -4.91 | — | -100.0 % | — | 0.0 % | 0.0 % | -1.8 | 44.5 % | 21.6 % | 4.0 (4) |
| ARMP Armata Pharmaceuticals Inc | 08/11 | +51 % | 56 5/22 | Stage 1 | D 29 | 4 of 9 | 0.2 $ | Biotechnology | Neutral | — | — | Healthcare | 4.50 $ | +11.6 % | +0.8 % | +85.3 % | −60.2 % | +169.2 % | 91 | 42 | 11.0 % | 10.5 % | 1.27 | — | 0.0 | 31.3 | — | — | — | -3.5 | — | -215.2 % | 0.0 % | -3,439.4 % | -25.3 % | — | — | -5.2 % | — | 0.0 % | 0.0 % | -52.2 | 10.5 % | 1.9 % | — |
| AVTX Avalo Therapeutics Inc | 08/06 | -33 % | 41 4/22 | Stage 3 | E 17 | 2 of 9 | 1.0 $ | Biotechnology | – | — | — | Healthcare | 18.30 $ | -1.8 % | +2.0 % | +131.3 % | −25.8 % | +144.2 % | 91 | 42 | 7.7 % | 7.4 % | 0.79 | — | 0.0 | 9,860.0 | — | — | — | -0.2 | — | -66,988.1 % | 0.0 % | -88.8 % | -41.5 % | — | — | -86.6 % | — | 0.0 % | 0.0 % | -10.4 | 76.6 % | 24.0 % | 4.6 (8) |
| ESOA Energy Services Of America Corp | 08/10 | +201 % | 96 13/29 | Stage 2 | B 63 | 9 of 9 | 0.3 $ | Engineering & Construction | Neutral | — | — | Industrials | 14.40 $ | +126.3 % | +137.4 % | +33.0 % | −6.2 % | +47.1 % | 91 | 91 | 5.3 % | 5.4 % | 1.33 | 26.6 | 25.1 | 0.6 | 3.3 | 27.8 | — | 11.7 | — | 11.9 % | 2.1 % | 13.7 % | 5.7 % | 0.46 | — | +16.8 % | — | 0.9 % | 24.1 % | 5.7 | 55.5 % | 2.7 % | — |
| ALKS Alkermes Plc | 08/04 | +15 % | 68 6/22 | Stage 2 | C 53 | 1 of 9 | 8.2 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 49.00 $ | +71.8 % | +84.2 % | +84.9 % | −1.6 % | +14.3 % | 90 | 9 | 4.8 % | 4.2 % | 0.29 | 56.8 | 133.3 | 4.9 | 4.9 | 36.8 | 1.96 | 41.9 | -0.2 % | 87.2 % | 4.0 % | 9.4 % | 4.2 % | 0.90 | 41.1 % | -5.3 % | — | 0.0 % | 0.0 % | 4.9 | 110.5 % | 12.5 % | 4.1 (15) |
| INDV Indivior Pharmaceuticals, Inc. | 07/30 | +25 % | 68 6/22 | Stage 2 | B 61 | 4 of 9 | 4.5 $ | Drug Manufacturers - Specialty & Generic | Neutral | — | Healthcare | 40.00 $ | +11.4 % | +14.1 % | +98.1 % | −1.9 % | +27.1 % | 90 | 83 | 3.6 % | 3.6 % | 1.15 | 20.8 | 13.0 | 3.5 | 140.7 | — | — | 14.3 | 46.1 % | 85.0 % | 19.5 % | 12.2 % | 22.7 % | -3.49 | -12.0 % | +4.3 % | — | 0.0 % | 0.0 % | 3.6 | 107.5 % | 11.3 % | 4.7 (7) | |
| ATEN A10 Networks, Inc. | 08/04 | +48 % | 92 10/25 | Stage 2 | B 63 | 7 of 9 | 2.1 $ | Software - Infrastructure | – | — | — | Technology | 29.60 $ | +92.3 % | +102.9 % | +62.5 % | −1.3 % | +20.3 % | 90 | 71 | 4.1 % | 4.3 % | 1.14 | — | 41.5 | 7.1 | — | 41.6 | 14.76 | 24.8 | 17.3 % | 79.3 % | 14.9 % | 21.4 % | 5.2 % | — | 34.8 % | +11.0 % | — | 0.8 % | 32.9 % | 7.7 | 103.9 % | 13.5 % | 4.2 (6) |
| IOVA Iovance Biotherapeutics Inc | 08/06 | -15 % | 55 5/22 | Stage 2 | C 51 | 5 of 9 | 1.8 $ | Biotechnology | Neutral | — | Healthcare | 4.10 $ | +62.6 % | +46.7 % | +58.4 % | −25.2 % | +100.5 % | 90 | 42 | 7.9 % | 8.3 % | 0.69 | — | 0.0 | 6.2 | — | — | — | -8.7 | — | 39.4 % | -123.9 % | -47.5 % | -23.7 % | — | — | +60.6 % | — | 0.0 % | 0.0 % | -3.3 | 67.5 % | 24.0 % | 4.1 (12) | |
| PAYS Paysign Inc | 08/04 | +67 % | 80 8/25 | Stage 2 | A 81 | 6 of 9 | 0.5 $ | Software - Infrastructure | Neutral | — | — | Technology | 9.00 $ | +44.5 % | +55.2 % | +20.4 % | −13.1 % | +10.6 % | 90 | 84 | 5.4 % | 5.9 % | 0.72 | — | 37.3 | 5.6 | — | 7.3 | — | 23.4 | — | 60.4 % | 11.4 % | 22.1 % | 2.7 % | — | — | +40.5 % | — | 0.0 % | 0.0 % | 4.6 | 47.3 % | 3.5 % | 4.6 (5) |
| CLPT Clearpoint Neuro Inc | 08/11 | +61 % | 40 4/22 | Stage 3 | D 44 | 4 of 9 | 0.5 $ | Medical Devices | Neutral | — | — | Healthcare | 14.90 $ | +35.5 % | +34.1 % | +43.7 % | −40.3 % | +90.2 % | 90 | 42 | 11.6 % | 9.0 % | 1.24 | — | 12.1 | 11.1 | 23.8 | — | 0.61 | -7.1 | — | 62.3 % | -71.6 % | -149.7 % | -25.0 % | 3.38 | — | +17.8 % | — | 0.0 % | 0.0 % | -3.1 | 50.6 % | 12.8 % | 5.0 (2) |
| ATLC Atlanticus Holdings Corporation | 08/06 | +51 % | 41 4/22 | Stage 2 | B 71 | 6 of 9 | 1.6 $ | Credit Services | Uses AI | — | Financial Services | 105.50 $ | +51.4 % | +49.6 % | +112.6 % | −2.8 % | +19.4 % | 90 | 77 | 6.3 % | 6.0 % | 2.12 | — | 7.9 | 1.3 | — | 2.0 | — | 0.0 | — | 72.4 % | 21.4 % | 21.4 % | 2.5 % | — | — | +53.3 % | — | 0.0 % | 0.0 % | 4.5 | 25.0 % | 25.8 % | 4.3 (7) | |
| FSTR LB Foster Company | 08/10 | +74 % | 37 5/29 | Stage 2 | C 52 | 6 of 9 | 0.4 $ | Railroads | – | — | — | Industrials | 41.10 $ | +63.0 % | +59.5 % | +75.0 % | −2.6 % | -2.7 % | 90 | 4 | 3.9 % | 4.2 % | 1.14 | 40.0 | 29.4 | 0.8 | 2.5 | 12.3 | 0.82 | 13.4 | — | 21.5 % | 2.0 % | 6.4 % | 5.4 % | 0.48 | — | +1.7 % | — | 0.0 % | 0.0 % | 8.4 | 72.3 % | 4.5 % | 3.0 (1) |
| HSHP Himalaya Shipping Ltd. | 08/14 | +61 % | 90 11/29 | Stage 2 | B 63 | 7 of 9 | 0.7 $ | Marine Shipping | – | — | — | Industrials | 15.70 $ | +71.0 % | +58.7 % | +159.1 % | −17.9 % | +5.1 % | 90 | 97 | 4.0 % | 3.9 % | 0.96 | — | 9.2 | 5.2 | — | 12.2 | — | 12.8 | — | 78.8 % | 20.3 % | 18.3 % | 5.7 % | — | — | +6.7 % | — | 8.3 % | 108.4 % | 4.3 | 47.7 % | 3.5 % | 4.0 (1) |
| MG Mistras Group Inc | 08/05 | +56 % | 60 7/29 | Stage 2 | C 45 | 8 of 9 | 0.5 $ | Security & Protection Services | – | — | — | Industrials | 15.20 $ | +50.8 % | +38.6 % | +91.6 % | −4.4 % | +38.2 % | 90 | 21 | 3.7 % | 3.8 % | 0.89 | — | 14.6 | 0.7 | — | 607.5 | 0.91 | 9.0 | — | 31.6 % | 3.1 % | 10.4 % | 6.3 % | — | — | -0.8 % | — | 0.0 % | 0.0 % | 5.6 | 62.5 % | 9.9 % | 5.0 (1) |
| NNBR NN Inc | 08/05 | +11 % | 60 7/29 | Stage 2 | C 47 | 3 of 9 | 0.2 $ | Conglomerates | – | — | — | Industrials | 3.30 $ | +125.0 % | +204.2 % | +69.7 % | −17.3 % | +86.6 % | 90 | 42 | 12.4 % | 9.4 % | 2.57 | — | 21.7 | 0.4 | 6.9 | — | 0.83 | 21.4 | — | 15.0 % | -7.9 % | -21.9 % | -2.1 % | 1.52 | — | -9.1 % | — | 0.0 % | 0.0 % | 2.0 | 56.5 % | 5.7 % | — |
| SPIR Spire Global Inc | 08/12 | +124 % | 85 10/29 | Stage 2 | D 40 | 4 of 9 | 0.5 $ | Specialty Business Services | Sells AI | — | — | Industrials | 11.50 $ | +132.5 % | +114.7 % | +14.3 % | −38.3 % | +81.5 % | 90 | 42 | 9.1 % | 11.1 % | 2.52 | 7.4 | 0.0 | 6.7 | 5.2 | — | — | 5.9 | — | 42.3 % | 77.1 % | 101.2 % | -27.2 % | 0.13 | — | -35.2 % | — | 0.0 % | 0.0 % | -8.1 | 39.9 % | 11.8 % | 4.6 (5) |
| ZURA Zura Bio Limited Class A Ordinary Shares | 08/13 | -21 % | 42 4/22 | Stage 1 | D 32 | 3 of 9 | 0.5 $ | Biotechnology | – | — | — | Healthcare | 5.40 $ | -17.8 % | +25.1 % | +287.9 % | −39.0 % | +207.4 % | 90 | 42 | 9.7 % | 8.0 % | -0.04 | — | 0.0 | — | — | — | — | -2.3 | — | — | 0.0 % | -41.0 % | -25.4 % | — | — | — | — | 0.0 % | 0.0 % | 23.1 | 78.6 % | 14.5 % | 4.6 (7) |
| LGND Ligand Pharmaceuticals Incorporated | 08/06 | +94 % | 54 5/22 | Stage 2 | B 58 | 5 of 9 | 5.4 $ | Biotechnology | – | — | — | Healthcare | 287.50 $ | +47.8 % | +59.3 % | +118.5 % | −1.4 % | +12.5 % | 89 | 86 | 5.6 % | 4.1 % | 0.98 | 38.4 | 32.3 | 19.7 | 5.9 | 43.9 | 1.53 | 24.2 | 33.6 % | 83.2 % | 56.0 % | 17.1 % | 5.2 % | 0.51 | 65.1 % | +60.4 % | — | 0.0 % | 0.0 % | 10.8 | 106.4 % | 11.5 % | 4.6 (7) |
| VIRT Virtu Financial, Inc. | 07/29 | +98 % | 96 10/22 | Stage 2 | B 55 | 3 of 9 | 12.6 $ | Capital Markets | – | — | — | Financial Services | 58.70 $ | +92.3 % | +74.0 % | +36.2 % | −5.9 % | +13.7 % | 89 | 83 | 4.6 % | 3.8 % | 0.58 | 9.7 | 9.8 | 3.1 | 2.9 | 26.1 | — | 6.4 | 46.8 % | 65.8 % | 16.9 % | 56.9 % | 4.5 % | 2.68 | 6.9 % | +26.3 % | — | 1.6 % | 14.6 % | 4.7 | 92.4 % | 5.8 % | 3.3 (9) |
| ASTH Astrana Health Inc | 08/06 | +13 % | 70 6/22 | Stage 2 | B 62 | 5 of 9 | 1.8 $ | Medical Care Facilities | Uses AI | — | Healthcare | 35.60 $ | +66.1 % | +79.3 % | +49.0 % | −0.5 % | +38.6 % | 89 | 87 | 3.6 % | 3.8 % | 0.89 | — | 23.0 | 0.5 | — | 11.4 | — | 14.4 | 3.0 % | 10.7 % | 0.9 % | 5.7 % | 3.6 % | — | 33.9 % | +56.4 % | — | 0.0 % | 0.0 % | 5.2 | 61.5 % | 10.3 % | 4.5 (12) | |
| WTTR Select Energy Services Inc | 08/04 | +56 % | 56 2/10 | Stage 2 | C 52 | 6 of 9 | 2.6 $ | Oil & Gas Equipment & Services | – | — | — | Energy | 18.50 $ | +78.1 % | +85.5 % | +97.0 % | −6.4 % | +21.6 % | 89 | 30 | 3.5 % | 3.8 % | 0.96 | 88.0 | 23.5 | 1.8 | 2.3 | — | — | 10.7 | 6.5 % | 28.1 % | 1.5 % | 2.1 % | 1.7 % | 0.29 | 58.1 % | -3.1 % | — | 1.5 % | 120.7 % | 5.6 | 97.7 % | 5.0 % | 5.0 (5) |
| NUVB Nuvation Bio Inc | 08/06 | +81 % | 69 6/22 | Stage 2 | B 67 | 6 of 9 | 2.1 $ | Biotechnology | – | — | — | Healthcare | 6.30 $ | -32.6 % | -41.1 % | +168.2 % | −40.4 % | +102.8 % | 89 | 42 | 7.2 % | 7.6 % | 1.53 | — | 0.0 | 14.7 | 7.6 | — | — | 2.2 | 4.7 % | 90.8 % | -102.1 % | -39.5 % | -17.0 % | 0.03 | 52.4 % | +699.0 % | — | 0.0 % | 0.0 % | 2.5 | 64.9 % | 26.5 % | 4.6 (7) |
| AMLX Amylyx Pharmaceuticals Inc | 08/06 | -10 % | 39 4/22 | Stage 3 | D 28 | 3 of 9 | 2.3 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 20.30 $ | +35.5 % | +49.7 % | +152.9 % | −6.9 % | +22.6 % | 89 | 42 | 6.8 % | 6.2 % | -0.20 | — | 2.8 | — | — | — | — | -11.7 | 0.0 % | — | 0.0 % | -63.3 % | -38.8 % | — | 93.0 % | -100.0 % | — | 0.0 % | 0.0 % | 11.1 | 105.3 % | 14.3 % | 4.6 (7) |
| AMN AMN Healthcare Services Inc | 08/06 | -23 % | 93 9/22 | Stage 2 | B 59 | 8 of 9 | 1.3 $ | Medical Care Facilities | Threatened | — | Healthcare | 33.60 $ | +98.2 % | +102.2 % | +83.4 % | −2.4 % | -5.2 % | 89 | 93 | 4.9 % | 5.2 % | 0.42 | — | 26.2 | 0.4 | — | 1.8 | 1.71 | 7.5 | — | 27.6 % | -1.0 % | -4.5 % | 3.5 % | — | — | -8.5 % | — | 0.0 % | 0.0 % | 5.6 | 115.6 % | 11.1 % | 3.3 (9) | |
| CARE Carter Bank and Trust | 07/23 | +38 % | 69 6/22 | Stage 2 | B 62 | 7 of 9 | 0.8 $ | Banks - Regional | Neutral | — | Financial Services | 34.60 $ | +65.1 % | +68.4 % | +99.7 % | −1.1 % | -8.0 % | 89 | 96 | 2.7 % | 2.8 % | 0.51 | — | 13.7 | 2.4 | — | 2.4 | — | 0.0 | — | 100.0 % | 44.9 % | 23.9 % | 2.7 % | — | — | +6.2 % | — | 1.2 % | 12.5 % | -1.9 | 59.2 % | 8.6 % | 4.7 (3) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Minervini/Qullamaggie Power Trend: the daily low has stayed above the 21-day EMA for at least 10 days, the 21-EMA has been above the 50-day SMA for at least 5 days, and the 50-SMA is rising — the condition in which trend traders are fully invested. When the Power Trend ends, they reduce risk.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 1147 stocks pass this scanner's criteria (as of 3. August 2026). The 100 strongest hits are shown.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- 21-EMA Trend
- Above 21-EMA Pullback
- Above the 50- & 200-SMA
- Ameet Rai: Daily Liquidity
- CANSLIM Type RS
- Character Change (CC)
- Chris Perruna: Daily New Highs
- Chris Perruna: Within 15% of Highs
- Gary Antonacci: Dual Momentum (Stock Adaptation)
- High ADR (≥5%)
- Jeff Sun
- Kathy Donnelly: Liquid Movers Up
- Mark Minervini: Trend Criteria — 1 Month
- Mike Webster: Cross Fire
- Mike Webster: Down Days Tell Screen
- Mike Webster: Power Trend Leader
- Mike Webster: Swing Trading List
- Near 52-Week High
- Oliver Kell: 52 Week Highs
- Oliver Kell: Doublers
- Oliver Kell: Strength on Down Day
- Qullamaggie: Top Gainers 1M
- Qullamaggie: Top Gainers 3M
- Qullamaggie: Top Gainers 6M
- Qullamaggie: Trend Intensity (13/65)
- RS Leader (≥90)
- RS New Highs
- Richard Moglen: 1 Week Top Performers
- Richard Moglen: Gaps and Strong Moves
- Richard Moglen: Top Performers 3/6 Month
- Stage 2 Leader
- Stan Weinstein: Checklist
- Stan Weinstein: Stage 1
- Stan Weinstein: Stage 2
- Stan Weinstein: Stage 3
- Strength on Stress Days
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.